Kidney image analysis services

Quantitative evaluation of renal pathology images plays an important role for your drug development studies. It will increase the precision and reproducibility of biomarker scoring and provides objective information about the status of the kidney specimens.


Aiosyn harnesses the power of cutting-edge AI technology to quantify kidney histopathology specimens. Our NephroPath1 platform consists of algorithms for AI-enabled kidney biomarker scoring and is offered through our AI-assisted image analysis services.

AI-powered (pre)clinical studies

Automated quantification and multi-class prediction on whole kidney digital slides through the NephroPath platform. In addition to model predictions, we deliver in-depth reports that include analysis results per experimental group in ongoing studies.

Aiosyn’s streamlined project workflow

  1. The NephroPath platform is for Research Use Only and should not be used for diagnostic procedures.

AI-assisted image analyses

  • Standard whole kidney analysis
  • Custom kidney analysis
  • Enrich your study with AI-powered whole kidney tissue quantification. We offer insights into your data through: 

    Accurate segmentation and delineation of relevant kidney structures

    Extent of glomerulosclerosis and fibrosis

    (Immune) cell quantification, including spatial relation to tissue

    Online/offline access to all results

    Learn more
  • Leverage Aiosyn’s expertise in AI and the latest technology to create a tailored analysis for kidney tissue. We offer development and prototyping of robust and performant models with a quick turn-around time:

    IHC/Biomarker quantification in specific animal models 

    Treatment response grouping

    Tissue microenvironment analysis 

    Contact us

How can we assist your team?

Explore analyses